73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Pembrolizumab shows survival benefit for patients with renal cancer

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,
Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

by Johns Hopkins University School of MedicineJ1568 study treatment schema.Eligible patients with clinically resectable PDA received the first priming study treatment Cy-GVAX-based therapy (alone

Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

by Johns Hopkins University School of MedicineJ1568 study treatment schema.Eligible patients with clinically resectable PDA received the first priming study treatment Cy-GVAX-based therapy (alone
Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich
PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr
Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di
Cancer metastasis: Tumor plasticity counts

Cancer metastasis: Tumor plasticity counts

by Université libre de BruxellesCredit: CC0 Public DomainCancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality. To under

Cancer metastasis: Tumor plasticity counts

by Université libre de BruxellesCredit: CC0 Public DomainCancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality. To under
Tracking radiation treatment in real time promises safer, more effective cancer therapy

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi
Unvaccinated cancer patients with COVID seven times more likely to die than comparable patients without COVID

Unvaccinated cancer patients with COVID seven times more likely to die than comparable patients without COVID

byRegenstrief InstituteKaplan-Meier survival estimates of overall cancer population by age group (years), Indiana, 2019-2020. Credit:JMIR Cancer(2022). DOI: 10.2196/35310Unvaccinated

Unvaccinated cancer patients with COVID seven times more likely to die than comparable patients without COVID

byRegenstrief InstituteKaplan-Meier survival estimates of overall cancer population by age group (years), Indiana, 2019-2020. Credit:JMIR Cancer(2022). DOI: 10.2196/35310Unvaccinated
Knocking out part of the innate immune system to improve cancer therapy

Knocking out part of the innate immune system to improve cancer therapy

by Justin Jackson , Medical XpressCredit: CC0 Public DomainResearchers at Shanghai Jiao Tong University School of Medicine, China, have discovered that shutting down part of the innate immune system i

Knocking out part of the innate immune system to improve cancer therapy

by Justin Jackson , Medical XpressCredit: CC0 Public DomainResearchers at Shanghai Jiao Tong University School of Medicine, China, have discovered that shutting down part of the innate immune system i
Study reveals lower survival rates for women than men with germ cell tumors

Study reveals lower survival rates for women than men with germ cell tumors

by Uppsala UniversityThe cell of origin, the normal development of sperm and oocytes, and the corresponding tumor development of malignant ovarian and testicular germ cell tumors. Credit:Jo

Study reveals lower survival rates for women than men with germ cell tumors

by Uppsala UniversityThe cell of origin, the normal development of sperm and oocytes, and the corresponding tumor development of malignant ovarian and testicular germ cell tumors. Credit:Jo
Researchers block two cancer cell signaling pathways and slow tumor growth

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t
Team pioneers cancer treatment that targets bone metastases while sparing bone

Team pioneers cancer treatment that targets bone metastases while sparing bone

by University of California, IrvineCredit: CC0 Public DomainUniversity of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells

Team pioneers cancer treatment that targets bone metastases while sparing bone

by University of California, IrvineCredit: CC0 Public DomainUniversity of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells